Skip to main content Skip to section navigation Skip to footer
Back to AchieveLifeSciences.com
Achieve Life Sciences, Inc. Investor Relations
  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Information

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 11, 2021 8:00am EST

Achieve Life Sciences to Present at the MicroCap Rodeo Winter Wonderland Conference on February 16, 2021

Jan 07, 2021 5:30am EST

Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference

Dec 07, 2020 4:05pm EST

Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option

Dec 03, 2020 8:00am EST

Achieve Life Sciences Announces Pricing of $15 Million Public Offering

Nov 30, 2020 7:00am EST

Achieve Life Sciences Announces Proposed Public Offering

Nov 12, 2020 4:05pm EST

Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update

Oct 29, 2020 5:30am EDT

Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020

Oct 27, 2020 5:30am EDT

Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020

Oct 08, 2020 6:30am EDT

Achieve Life Sciences Announces to Present at the MicroCap Best Ideas Conference, October 13, 2020

Oct 07, 2020 6:30am EDT

Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation

  • Previous Pagearrow_back
  • Page 1…
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • …Page 17
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Achieve Life Sciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap